Sarah Sherwood | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Community Leaders
Sarah Sherwood

Sarah Sherwood, BA

Community Leader
Amyloidosis Israel Organization
Israel

Sara Sherwood was born in Kiryat Ata and did her graduation (BA) in Law and Geography, at the Hebrew University of Jerusalem. During her academic life, she also took a tour guide course in the Ministry of Tourism and worked on group guidance. She became a lawyer in 1989 and currently serves as a legal advisor in a government company.

Following a cardiac arrest she received in 2004, she was diagnosed with AL amyloidosis and underwent two bone marrow transplants in a Boston hospital, one in 2004 and the other in 2006. After recurrence of the disease, she was treated first with Bortezomib and then with Velcade (VCD).

About three years after the treatment began, her illness stabilized, her friend Laci Kemer was the first to work with amyloidosis patients and had support groups. In 2011, along with Danny Dreamer (Daniel Drimer), they expanded their activities to help patients with amyloidosis and promote awareness of the disease in the medical community. In addition, they worked together to gather more members, and in November 2016, they founded the Amyloidosis Israel Organization.

Sara Sherwood is a member of the association committee from its inception in November 2016. She is married and is a mother to a daughter and two sons.
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close